TI
CABA icon

Trexquant Investment’s Cabaletta Bio CABA Stock Holding History

Trexquant Investment’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-144,584
Closed -$682K – 1574
2024
Q3 		$682K Buy
144,584
+116,351
+412% +$673K 0.01% 1174
2024
Q2 		$211K Sell
28,233
-41,184
-59% -$505K ﹤0.01% 1436
2024
Q1 		$1.18M Buy
+69,417
New +$1.49M 0.02% 852
2023
Q2 		– Sell
-10,511
Closed -$86.9K – 1468
2023
Q1 		$86.9K Buy
+10,511
New +$98.4K ﹤0.01% 1382

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Trexquant Investment's CABA Position: Q4 2024 in Review

Trexquant Investment sold out of Cabaletta Bio (CABA) in Q4 2024, closing a stake of 144,584 shares — an estimated $682K sold.

Trexquant Investment first reported a position in CABA in Q1 2023 and held it in 4 quarters. The position peaked at $1.18M in Q1 2024. 108 funds tracked by Wall St. Rank hold CABA as of Q4 2024.

  • Trexquant Investment reported no remaining Cabaletta Bio position as of Q4 2024 after selling out during the quarter.
  • Trexquant Investment sold 144,584 Cabaletta Bio shares in Q4 2024, an estimated $682K.
  • Trexquant Investment first reported a position in Cabaletta Bio in Q1 2023 and held it in 4 quarters.
  • Trexquant Investment's Cabaletta Bio position peaked at $1.18M in Q1 2024.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2024.

Based on Trexquant Investment's 13F filing for Q4 2024, filed 12 Feb 2025.